A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
AbbVie
Massachusetts General Hospital
M.D. Anderson Cancer Center
Thomas Jefferson University
Constellation Pharmaceuticals
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
Ohio State University Comprehensive Cancer Center
Incyte Corporation
Celgene
Masonic Cancer Center, University of Minnesota
American Regent, Inc.
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
City of Hope Medical Center
Icahn School of Medicine at Mount Sinai
Stemline Therapeutics, Inc.
University Hospital, Angers
Vanderbilt-Ingram Cancer Center
Ottawa Hospital Research Institute
City of Hope Medical Center
Dartmouth-Hitchcock Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Celgene
University Health Network, Toronto
Herlev Hospital
Sierra Oncology LLC - a GSK company
M.D. Anderson Cancer Center
Northside Hospital, Inc.
Prelude Therapeutics
Gruppo Italiano Trapianto di Midollo Osseo
Icahn School of Medicine at Mount Sinai
University of Virginia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Roswell Park Cancer Institute
University of Alabama at Birmingham
Incyte Corporation
Odense University Hospital
NS Pharma, Inc.
Hoffmann-La Roche
University of Rochester
Geron Corporation
H. Lee Moffitt Cancer Center and Research Institute
Northwestern University
Incyte Corporation